Clinical Research Organizations: Ensuring Efficiency
By advancing the globalization of clinical trials and the drug development process, ACRO members are committed to improving efficiency in the field of biomedical research.
According to the independent Tufts Center for the Study of Drug Development:
- Clinical trials conducted by CROs—like the ones that make up ACRO’s membership—are completed on average 30 percent more quickly than those conducted in-house.
- This results in an average time savings of somewhere between four and five months, which translates to $120 million to $150 million in increased revenue potential.
When it comes to medical research and the drug development process, time really is money. That’s why CROs are working to enhance efficiency in the clinical research process by encouraging innovation and leading the globalization of clinical research.